Cargando…

Effects of GLP-1 receptor agonists on asprosin levels in normal weight or overweight/obesity patients with type 2 diabetes mellitus

Asprosin is a newly identified adipokine with glucose-raising and appetite-enhancing effects which acts differently from the known hepatic glucose utilization pathway. This study investigated changes in serum asprosin levels in normal weight or overweight/obese liraglutide-treated patients with type...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Chenggang, Zhu, Weifeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	4300
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622638/ https://www.ncbi.nlm.nih.gov/pubmed/36316938 http://dx.doi.org/10.1097/MD.0000000000031334

Ejemplares similares

GLP-1 receptor agonists modulate blood glucose levels in T2DM by affecting Faecalibacterium prausnitzii abundance in the intestine
por: Liang, Lei, et al.
Publicado: (2023)

Pharmacotherapy weight-loss interventions to prevent type 2 diabetes in overweight or obese adults and older adults: A protocol for systematic review and network meta-analysis
por: Yang, Wenxiao, et al.
Publicado: (2021)

Serum leptin, resistin, and adiponectin levels in obese and non-obese patients with newly diagnosed type 2 diabetes mellitus: A population-based study
por: Liu, Wei, et al.
Publicado: (2020)

Impaired rate-dependent depression of the H-reflex in type-2 diabetes, prediabetes, overweight and obesity: A cross-sectional study
por: Salinas, Luisa Fernanda, et al.
Publicado: (2022)

Effect of long-acting versus short-acting glucagon-like peptide-1 receptor agonists on improving body weight and related metabolic parameters in type 2 diabetes: A head-to-head meta-analysis
por: Yuan, Xia, et al.
Publicado: (2023)

Irisin is a predictor of sarcopenic obesity in type 2 diabetes mellitus: A cross-sectional study
por: Oguz, Ayten, et al.
Publicado: (2021)

Maturity-Onset diabetes of the young type 5 treated with the glucagon-like peptide-1 receptor agonist: A case report
por: Terakawa, Aiko, et al.
Publicado: (2020)

Effects of bariatric surgery in Chinese with obesity and type 2 diabetes mellitus: A 3-year follow-up
por: Zuo, Didi, et al.
Publicado: (2020)

Comparative efficacy and safety of glucagon-like peptide 1 receptor agonists for the treatment of type 2 diabetes: A network meta-analysis
por: Chen, Han, et al.
Publicado: (2023)

Efficacy of traditional Chinese exercises in improving anthropometric and biochemical indicators in overweight and obese subjects: A systematic review and meta-analysis
por: Yang, Qianfang, et al.
Publicado: (2023)

Association of plasminogen activator inhibitor-1 and fibroblastic growth factor 21 in 3 groups of type 2 diabetes: Without overweight/obesity, free of insulin resistance, and without hepatosteatosis
por: Takebe, Noriko, et al.
Publicado: (2023)

High Serum Irisin Level as an Independent Predictor of Diabetes Mellitus: A Longitudinal Population-Based Study
por: Huh, Ji Hye, et al.
Publicado: (2016)

Effect of SGLT inhibitors on weight and lipid metabolism at 24 weeks of treatment in patients with diabetes mellitus: A systematic review and network meta-analysis
por: Chen, Mao-bing, et al.
Publicado: (2021)

Seasonal Variations of Severe Hypoglycemia in Patients With Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, and Non-diabetes Mellitus: Clinical Analysis of 578 Hypoglycemia Cases
por: Tsujimoto, Tetsuro, et al.
Publicado: (2014)

Beclin1 circulating level as predictor of carotid intima-media thickness in patients with type 2 diabetes mellitus
por: Naguib, Mervat, et al.
Publicado: (2021)

Liddle syndrome presenting with normal aldosterone levels: A case report
por: Wang, Rongrong, et al.
Publicado: (2023)

Treated glycosylated hemoglobin levels in individuals with diabetes mellitus vary little by health status: A retrospective cohort study
por: McAlister, Finlay A., et al.
Publicado: (2016)

Circulating LECT2 levels in newly diagnosed type 2 diabetes mellitus and their association with metabolic parameters: An observational study
por: Zhang, Zhen, et al.
Publicado: (2018)

The efficacy and safety of combined GLP-1RA and basal insulin therapy among inadequately controlled T2D with premixed insulin therapy
por: Liu, Jhih-Syuan, et al.
Publicado: (2023)

Effects of different weight loss dietary interventions on body mass index and glucose and lipid metabolism in obese patients
por: Ma, Yahui, et al.
Publicado: (2023)

Association of vitamin D receptor gene polymorphism with type 1 diabetes mellitus risk in children: A protocol for systematic review and meta-analysis
por: Ran, Yalin, et al.
Publicado: (2021)

Correlation analysis of IGF-1, ZAG, nesfatin-1, HbA(1c) levels, and type 2 diabetes mellitus complicated with hypothyroidism
por: He, Shuangling, et al.
Publicado: (2021)

Effects of tofogliflozin on adrenocorticotropic hormone, renin and aldosterone, and cortisol levels in elderly patients with diabetes mellitus: A retrospective study of a patient cohort
por: Higashikawa, Toshihiro, et al.
Publicado: (2021)

Association between uric acid level and incidence of albuminuria in patients with type 2 diabetes mellitus: A 4.5-year cohort study
por: Lai, Yun-Ju, et al.
Publicado: (2021)

Effects of glucagon-like peptide 1 receptor agonists and sodium glucose cotransporter 2 inhibitors on major adverse cardiovascular events in type 2 diabetes by race, ethnicity, and region: A meta-analysis
por: Qiu, Mei, et al.
Publicado: (2020)

Total bilirubin level may be a biomarker of nephropathy in type 2 diabetes mellitus: A meta-analysis of observational studies based on MOOSE compliant
por: Zhang, Dan, et al.
Publicado: (2017)

Association of chemerin levels and bone mineral density in Chinese obese postmenopausal women
por: Shi, Liang, et al.
Publicado: (2016)

Sex difference determined the role of sex hormone-binding globulin in obese children during short-term weight reduction program
por: Wang, Fu-Min, et al.
Publicado: (2017)

Effects of different dosages of Sodium-Glucose Transporter 2 Inhibitors on lipid levels in patients with type 2 diabetes mellitus: A protocol for systematic review and meta-analysis
por: Cai, Tingyu, et al.
Publicado: (2020)

Metabolic syndrome independently predicts future diabetes in women with a history of gestational diabetes mellitus
por: Cho, Nam H., et al.
Publicado: (2016)

The relationship between neutrophil-to-lymphocyte ratio and diabetic peripheral neuropathy in Type 2 diabetes mellitus
por: Xu, Tingting, et al.
Publicado: (2017)

Acupuncture for chronic constipation in patients with diabetes mellitus: A protocol for systematic review
por: Cui, Sufen, et al.
Publicado: (2021)

Age at menopause was not associated with microvascular complications in patients with type 2 diabetes mellitus
por: Sun, Shuyao, et al.
Publicado: (2023)

Sintilimab-related diabetes mellitus and psoriasis: A case report and literature review
por: Huang, Wenying, et al.
Publicado: (2023)

Increased GABA concentrations in type 2 diabetes mellitus are related to lower cognitive functioning
por: van Bussel, Frank C.G., et al.
Publicado: (2016)

The association of two common polymorphisms in miRNAs with diabetes mellitus: A meta-analysis
por: Li, Guixin, et al.
Publicado: (2019)

Association between polymorphisms in microRNAs and susceptibility to diabetes mellitus: A meta-analysis
por: Chen, Xi, et al.
Publicado: (2019)

Metabolic outcomes in patients with type 2 diabetes mellitus after metabolic management center
por: Li, Xia, et al.
Publicado: (2022)

Diabetes distress, happiness, and its associated factors among type 2 diabetes mellitus patients with different therapies
por: Liu, Shun-Ying, et al.
Publicado: (2020)

Diabetes mellitus and the risk of bladder cancer: A PRISMA-compliant meta-analysis of cohort studies
por: Xu, Yongping, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kcmsi1q9krtqjfv0o8p8oq3mdt